Abstract 68 Ga prostate-specific membrane antigen (PSMA) PET/CT is increasingly used to
evaluate extent of disease in prostate carcinoma. Several other benign and malignant …

Addressing molecular targets, that are overexpressed by various tumor entities, using
radiolabeled molecules for a combined diagnostic and therapeutic (theranostic) approach is …

We present the case of an 87-year-old man with a history of melanoma metastatic to the
lungs found to have an FDG-negative liver lesion that was initially thought to be benign …

An 80-year-old man with suspected recurrent prostate carcinoma underwent 68 Ga-PSMA
PET/CT, which showed enlarged axillary lymph nodes with intensely increased 68 Ga …

This study aimed to synthesize a new 177 Lu-iPSMA-RGD heterobivalent
radiopharmaceutical, as well as to assess the in vitro radiopharmaceutical potential to target …

Discussion 68 Ga-PSMA-11 PET/CT is widely used in clinical practice to restage PCa in the
case of PSA failure after radical therapy. 1 According to the most recent literature, 68 Ga …

OBJECTIVE. The purpose of this study is to provide a concise summary of the current
experience with 68Ga-labeled prostate-specific membrane antigen (PSMA)–11 imaging of …

Optimized production, quality control and preclinical evaluation of 68Ga-PSMA-617 as a
PET radiotracer for PSMA-positive malignancies as well as successful application in …

Recently, we experienced the same false-positive uptake unilaterally in bilateral
gynecomastia on 68Ga-PSMA PET/CT scan. A 63-year-old patient was referred for 68Ga …

Abstract PSMA PET/CT is routinely used for the detection of prostate cancer (PC). However,
increased PSMA-ligand uptake has been described in a variety of benign and malignant …